Additionally, PMN-MDSCs can promote EMT in melanoma cells through activation of the TGF-β, epidermal growth factor (EGF) or hepatocyte growth factor (HGF) signaling pathways, leading to enhanced metastasis [84]. This evidence concerns the gene HGF and melanoma.